Skip to main content
. 2022 May 11;13:2576. doi: 10.1038/s41467-022-30216-8

Fig. 3. mACE2-CAR_sIL15 enhances NK cell cytotoxicity against target cells that express SARS-CoV-2 spike protein.

Fig. 3

a Representative real-time cell analysis (RTCA) data showing NK cell cytotoxicity against A549-spike or parental A549 cells at an effector (E)/target (T) ratio of 1:4. b RTCA data showing NK cell cytotoxicity against A549-spike or parental A549 cells at an E/T ratio of 1:8. c Data from the RTCA assay analyzed at three different E/T ratios are summarized for cells from 6 donors. P values were determined with one-way ANOVA with multiple comparisons and adjusted by the Hochberg method. Data are presented as mean ± SEM. d Expression of CD107a, TNF-α, and IFN-γ was measured on transduced NK cells co-cultured with A549-spike or parental A549 cells for 4 h at an E/T ratio of 4:1. Data are summarized for NK cells from 7 donors. P values were determined by one-way ANOVA with multiple comparisons and adjusted by the Holm-Sidak or Dunn’s method. Data are presented as mean ± SD. e IL-15 production by ex vivo-expanded control tEGFR NK cells or mACE2-CAR_sIL15 NK cells cultured in the presence or absence of A549-spike cells for 72 h. Data are summarized for NK cells from four donors. P values were determined by one-way ANOVA with multiple comparisons and adjusted by the Holm–Sidak method. Data are presented as mean ± SD. Source data are provided as a Source Data file.